Kuros Biosciences Ltd. Logo

Kuros Biosciences Ltd.

ISIN

CH0325814116

Ticker

KURN

Sector

Health Care

Sub-Industry

Biotechnology

Country

Switzerland

Year Founded

About Kuros Biosciences Ltd.

Company Description

With more than 150 years of combined research experience, we feel well-established as leaders in orthobiologics, but we're never content with resting on our laurels. Instead, we continue to forge beyond the accepted solutions for spinal fusion. Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Headcount

58

Served Area

Worldwide

Headquarters

Wagistrasse 25
8952, Schlieren
Switzerland

Insider Trades

Date Trading entity / Person Association Trade type Volume
05.06.2024 None Non-Executive member Buy CHF 173,965.00
04.06.2024 None Non-Executive member Buy CHF 49,950.00
03.06.2024 None Non-Executive member Buy CHF 49,830.00
27.05.2024 None Non-Executive member Buy CHF 4,963.75
22.05.2024 None Executive member Buy CHF 221,100.00
21.05.2024 None Non-Executive member Buy CHF 46,500.00
16.05.2024 None Non-Executive member Buy CHF 71,460.00
15.05.2024 None Executive member Sell CHF 3,120,216.00
15.05.2024 None Non-Executive member Sell CHF 1,698,824.00
07.05.2024 None Non-Executive member Buy CHF 48,750.00

Capital Markets Information

ISIN

CH0325814116

LEI

5299006U5POB2AVTT709

Sub-Industry

Biotechnology

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.